Covered recipient · General Payments record
AHMED A KHALAFALLAH
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$3,240.97
- Reported across 242 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $209.35 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $39.74 | 2 |
| Amgen Inc. | $37.36 | 2 |
| Acerta Pharma LLC | $34.71 | 2 |
| PFIZER INC. | $30.83 | 2 |
| Lexicon Pharmaceuticals, Inc. | $19.17 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $17.62 | 1 |
| Lilly USA, LLC | $15.56 | 1 |
| Otsuka America Pharmaceutical, Inc. | $14.36 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $18.69 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111617946 | CMS |
| Amgen Inc. | $18.67 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111617948 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.79 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104309346 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.92 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105691397 | CMS |
| Lexicon Pharmaceuticals, Inc. | $19.17 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1081719809 | CMS |
| Lilly USA, LLC | $15.56 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136012179 | CMS |
| Novartis Pharmaceuticals Corporation | $17.62 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087149044 | CMS |
| Novo Nordisk Inc | $23.25 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097578446 | CMS |
| Novo Nordisk Inc | $16.49 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096900881 | CMS |
| Otsuka America Pharmaceutical, Inc. | $14.36 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118920756 | CMS |
| PFIZER INC. | $14.72 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131018366 | CMS |
| PFIZER INC. | $16.11 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131952380 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.